期刊文献+

慢病毒载体pITA-HBP1的制备及感染效率的测定

Construction and Evaluation of Lentiviral Vector pITA-HBP1
下载PDF
导出
摘要 慢病毒载体是目前基因治疗中研究较多的载体,与通常使用的逆转录病毒载体和腺病毒载体比较,它有感染非分裂期细胞及容纳大片段外源性目的基因等优点.本文应用基因重组的方法,构建了1种新型的慢病毒载体,并将转录因子HBP1基因插入到这一载体上,成为pITA-HBP1.检测其在人的肿瘤细胞和正常细胞中的转染效率,发现转染效率明显增加,Western印迹证实外源基因得到高效表达.这一结果,对今后实验室提高基因的转染效率、表达水平,以及研究基因的表达调控,都提供了重要的技术方案. Lentiviral vectors have been widely used in gene therapy and in laboratory biological study for their ability to deliver larger gene fragments into cells in the non-dividing phase.In this study,we constructed a lentiviral vector pITA-HBP1 expressing the HBP1 transcription factor and evaluated its infection efficiency of the packaged lentivirus by Western blot.We found that both human tumor cells and normal cells were infected efficiently as determined by the expression of HBP1.Our results showed that HBP1 could be transduced exogenously into normal or cancer cells with our lentiviral system.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2010年第11期1044-1049,共6页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金面上项目(No.30770442)~~
关键词 慢病毒载体 转录因子HBP1 感染效率 lentiviral vector transcription factor HBP1 infection efficiency
  • 相关文献

参考文献15

  • 1CHEN-YU XU,YING GU,WANG-HENG HOU,YU-QIONG QUE,SHUANG-GUAN GAO,TONG CHENG,NING-SHAO XI.Tetracysteine as a Reporter for Gene Therapy[J].Biomedical and Environmental Sciences,2009,22(6):496-501. 被引量:1
  • 2Adam S. Cockrell,Tal Kafri.Gene delivery by lentivirus vectors[J]. Molecular Biotechnology . 2007 (3)
  • 3Shizuko Sei.Peptide nucleic acids as epigenetic inhibitors of HIV-1[J]. International Journal of Peptide Research and Therapeutics . 2003 (3-4)
  • 4Tang H,Kuhen KL,Flossie WS.Lentivirus replication andregulation. Annual Review of Genetics . 1999
  • 5Sung MH,Simon R.Genomewide conserved epitope profiles ofHIV-1 predicted by biophysical properties of MHC bindingpeptides. Journal of Computational Biology . 2004
  • 6Kock N,Kasmieh R,Weissleder R,et al.Tumor therapymediated by lentiviral expression of shBcl-2 and S-TRAIL. Neoplasia . 2007
  • 7Heldt SA,Ressler KJ.Amygdala-specific reduction of alpha1-GABAA receptors disrupts the anticonvulsant,locomotor,andsedative,but not anxiolytic,effects of benzodiazepines in mice. The Journal of Neuroscience . 2010
  • 8Wu Y,Beddall MH,Marsh JW.Rev-dependent lentiviralexpression vector. Retrovirology . 2007
  • 9Mautino MR.Lentiviral vectors for gene therapy of HIV-1 infection. Current Gene Therapy . 2002
  • 10Zhang,X,Kim,J,Ruthazer,R,McDevitt,MA,Wazer,DE,Paulson,KE,Yee,AS.The HBP1 transcriptional repressor participates in RAS-induced premature senescence. Molecular and Cellular Biology . 2006

二级参考文献29

  • 1Greet L F, 3rd, Szalay A A (2002). Imaging of light emissionfrom the expression of luciferases in living cells and organisms: a review. Luminescence 17(1), 43-74.
  • 2Gross S, Piwnica-Worms D (2005). Spying on cancer: molecular imaging in vivo with genetically encoded reporters. Cancer Cell 7(1), 5-15.
  • 3Wahlfors J, Loimas S, Pasanen T, et al. (2001). Green fluorescent protein (GFP) fusion constructs in gene therapy research. Histochem Cell Biol 115(1 ), 59-65.
  • 4Andresen M, Schmitz-Salue R, Jakobs S. (2004). Short tetracysteine tags to beta-tubulin demonstrate the significance of small labels for live cell imaging. Mol Biol Cell 15(12), 5616-5622.
  • 5Griffin B A, Adams S R, Tsien R Y. (1998). Specific covalent labeling of recombinant protein molecules inside live cells. Science 281(5374), 269-272.
  • 6Chinnasamy D, Milsom M D, Shaffer J, et al. (2006). Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI. Virol J 3, 14.
  • 7Ben-Dor I, ltsykson P, Goldenberg D, et al. (2006). Lentiviral vectors harboring a dual-gene system allow high and homogeneous transgene expression in selected polyclonal human embryonic stem cells. Mol Ther 14(2), 255-267.
  • 8Kramer B A, Lemckert F A, Alexander I E, et al. (2006) Characterization of a P140K mutant O6-methylguanine-DN A-met hyltransferase (MGMT)-expressing transgenic mouse line with drug-selectable bone marrow. J Gene Med 8(9), 1071-1085.
  • 9Osti D, Marras E, Ceriani I, et al. (2006). Comparative analysis of molecular strategies attenuating positional effects in lentivirat vectors carrying multiple genes. J Virol Methods 136(1-2), 93-101.
  • 10Adams S R, Campbell R E, Gross L A, et al. (2002). New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications. J Am Chem Soc 124(21 ),6063-6076.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部